Heterochromatin Protein 1 Deleted Chromo Domain Decreases Gene Silencing of Transgene in Mouse

被引:0
|
作者
Feng-Tao Liu
Yan Zhang
机构
[1] Shanghai Jiao Tong University,Institute of Medical Genetics
[2] Henan University,Medical School
来源
Biotechnology Letters | 2006年 / 28卷
关键词
bioreactor; chromo domain; dominant-negative effect; gene silencing; heterochromatin protein 1;
D O I
暂无
中图分类号
学科分类号
摘要
The heterochromatin protein 1 (HP1) regulates epigenetic gene silencing by promoting and maintaining chromatin condensation. To decrease gene silencing, the chromo domain (CD) in the M31 (the main HP1 in mouse) was deleted by site-directed mutagenesis. Vector pcDNA3.1(+)/M31-ΔCD, in which the M31-ΔCD is driven by the CMV promoter, and vector pcDNA3.1(+)/P1A3-M31-ΔCD, in which the M31-ΔCD is driven by a goat ß-casein promoter were constructed. The former vector was transfected into a murine fibroblast cell line, which can express enhanced green fluorescent protein (EGFP). EGFP expression, which was determined by flow cytometric analysis, increased approximately 80% in the transfected cells. After injection of the latter vector into transgenic mouse mammary glands, which can express human clotting factor IX (hFIX), the hFIX expression level in the mouse milk increased approximately 40–60% and hFIX in one mouse milk was maintained at a high concentration for over 10 days.
引用
收藏
页码:419 / 424
页数:5
相关论文
共 50 条
  • [21] Conformational plasticity of the multi-domain Heterochromatin Protein 1β
    Munari, F.
    Rezaei-Ghaleh, N.
    Xiang, S.
    Fischle, W.
    Zweckstetter, M.
    EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS, 2013, 42 : S171 - S171
  • [22] Heterochromatin protein 1γ deficiency decreases histone H3K27 methylation in mouse neurosphere neuronal genes
    Naruse, Chie
    Abe, Kanae
    Yoshihara, Toru
    Kato, Tomoaki
    Nishiuchi, Takumi
    Asano, Masahide
    FASEB JOURNAL, 2020, 34 (03): : 3956 - 3968
  • [23] The changing faces of HP1: From heterochromatin formation and gene silencing to euchromatic gene expression
    Kwon, So Hee
    Workman, Jerry L.
    BIOESSAYS, 2011, 33 (04) : 280 - 289
  • [24] Drosophila heterochromatin protein 1 (HPI)/origin recognition complex (ORC) protein is associated with HP1 and ORC and functions in heterochromatin-induced silencing
    Shareef, MM
    King, C
    Damaj, M
    Badagu, R
    Huang, DW
    Kellum, R
    MOLECULAR BIOLOGY OF THE CELL, 2001, 12 (06) : 1671 - 1685
  • [25] Gene regulation by human orthologs of Drosophila heterochromatin protein 1
    Hwang, KK
    Worman, HJ
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2002, 293 (04) : 1217 - 1222
  • [26] LHP1, the Arabidopsis homologue of HETEROCHROMATIN PROTEIN1, is required for epigenetic silencing of FLC
    Mylne, JS
    Barrett, L
    Tessadori, F
    Mesnage, S
    Johnson, L
    Bernatavichute, YV
    Jacobsen, SE
    Fransz, P
    Dean, C
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (13) : 5012 - 5017
  • [27] Phosphorylation site mutations in heterochromatin protein 1 (HP1) reduce or eliminate silencing activity
    Zhao, T
    Heyduk, T
    Eissenberg, JC
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (12) : 9512 - 9518
  • [28] Phosphorylation of Swi6/HP1 regulates transcriptional gene silencing at heterochromatin
    Shimada, Atsushi
    Dohke, Kohei
    Sadaie, Mahito
    Shinmyozu, Kaori
    Nakayama, Jun-Ichi
    Urano, Takeshi
    Murakami, Yota
    GENES & DEVELOPMENT, 2009, 23 (01) : 18 - 23
  • [29] Mutant mouse p53 transgene elevates the chemical induction of tumors that respond to gene silencing with siRNA
    H Tanooka
    K Tatsumi
    H Tsuji
    Y Noda
    T Katsube
    H Ishii
    A Ootsuyama
    F Takeshita
    T Ochiya
    Cancer Gene Therapy, 2010, 17 : 1 - 10
  • [30] Mutant mouse p53 transgene elevates the chemical induction of tumors that respond to gene silencing with siRNA
    Tanooka, H.
    Tatsumi, K.
    Tsuji, H.
    Noda, Y.
    Katsube, T.
    Ishii, H.
    Ootsuyama, A.
    Takeshita, F.
    Ochiya, T.
    CANCER GENE THERAPY, 2010, 17 (01) : 1 - 10